Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is a prescription-only medicine licensed in the UK for adults with a BMI of 30 or above, or a BMI of 27 or above when at least one weight-related health condition is present. If your BMI sits below 30, the honest answer is that the licensed eligibility criteria almost certainly won't be met — but the exact picture depends on your full clinical history, which is why a prescriber, not a number on a scale alone, makes the call. These are Prescription-Only Medicines: a clinician must assess you before any prescription can lawfully be issued. See how the full access process works in the UK.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The UK licence for Mounjaro sets a BMI threshold of 30 as the baseline for weight-management use. A lower threshold of 27 applies when a qualifying health condition is also present, conditions such as high blood pressure, type 2 diabetes, prediabetes, high cholesterol, obstructive sleep apnoea or osteoarthritis. The Mounjaro overview page covers the full eligibility picture in detail.
For people below BMI 27, the medicine falls outside its licensed weight-management indication. That is not a grey area a prescriber can work around; it is the boundary set by the MHRA on the basis of the clinical evidence. NICE's appraisal of tirzepatide (TA1026) recommends its use at BMI 35 or above for NHS access, with the private licensed threshold remaining at 30 (or 27 with a comorbidity). Lower BMI thresholds do apply for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds under UK clinical guidance (typically 2.5 kg/m² lower) so if your background is relevant here, that adjustment is worth raising at consultation. Read more about the criteria for Mounjaro for weight loss.
The short version: if your BMI is between 27 and 29.9 and you have a relevant health condition, there is a clinical conversation worth having. Below 27, the medicine is not licensed for weight management and a prescriber cannot lawfully prescribe it for that purpose.
BMI is a screening tool, not a diagnosis. Prescribers use it as one input alongside your health history, current conditions, medications and what you are actually trying to achieve. Someone at BMI 28 with well-documented hypertension and prediabetes sits within the licensed criteria. Someone at BMI 29 with no qualifying conditions does not, regardless of how they feel about their weight.
This is why the consultation matters. The clinical team at nume reviews every consultation personally, checking the full picture, not just a single figure submitted on a form. That review happens the same day. It is also why a prescriber will sometimes decline: the medicine has a defined licence, and prescribing outside it would not be in the patient's interest or in line with the prescriber's professional obligations.
If you are unsure where you sit, the NHS BMI calculator gives you a starting point before you consult. It takes 30 seconds and tells you where your current weight lands against the thresholds described above.
Mounjaro is a Prescription-Only Medicine. The only lawful route to it in the UK is a valid prescription issued by a registered prescriber following a clinical assessment, dispensed by a pharmacy regulated by the GPhC. That applies whether you are consulting online or in person. How to buy Mounjaro online safely covers what to look for when choosing a provider.
The MHRA has warned repeatedly about counterfeit weight-loss pens sold through social media and websites that operate without clinical oversight. In October 2025, enforcement teams raided the first UK site manufacturing fake tirzepatide pens, around 20 million doses of illegally traded weight-loss medicines, worth roughly £45 million, were seized across 2025 alone. Fake pens have contained the wrong active ingredient, including insulin, which has caused hospitalisations. The red flags are consistent: offers of these medicines without a prescription, prices far below the market, and supposed discount codes from sellers you cannot verify. Suspect sellers can be reported via the MHRA Yellow Card scheme.
Any legitimate online pharmacy can be checked on the GPhC register. The direct link for nume's GPhC entry is registration number 9012878, look it up before you order from any pharmacy, ours included. Worth checking.
If Mounjaro is not the right fit right now, that is not the end of the road. Wegovy (semaglutide) carries a similar licensed eligibility profile and may suit people who prefer a once-weekly injection through a GLP-1 mechanism. The weight-loss treatments overview sets out what is available through nume and how the options compare, so you can arrive at a consultation with a clearer sense of direction.
It is also worth knowing that eligibility can change. If your BMI or health conditions shift, returning for a fresh consultation makes sense. Those who have already worked through earlier doses and are looking at Mounjaro 15mg through an online pharmacy will find that page covers the process and what to expect at that stage. If you have questions about getting Mounjaro without a diabetes diagnosis specifically, that page addresses the distinction in more detail.
If you want to speak to a prescriber about your circumstances, start a free consultation and a clinician will review it the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.